Search for 'Provider:Clinical and Translational Oncology,'

GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance status.

By Manneh Kopp, Ray . Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2016 . 18(8):805-12. , Formato Vancouver: Pérez Segura P, Manneh R, Ceballos I, García A, Benavides M, Fuster J et al. GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance status. Clin Transl Oncol. 2016 Aug;18(8):805-12.

Place Hold on GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance status.

Current Challenges in Cancer Treatment.

By Zugazagoitia, Jon | Guedes, Cristiano | Ponce Aix, Santiago | Ferrer, Irene | Molina Pinelo, Sonia | Paz-Ares Rodríguez, Luis. Clinical therapeutics, 2016 . 38(7):1551-66. , Formato Vancouver: Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina Pinelo S, Paz Ares L. Current Challenges in Cancer Treatment. Clin Ther. 2016 Jul;38(7):1551-66.

Place Hold on Current Challenges in Cancer Treatment.

SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015.

By García Carbonero, Rocío . Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2015 . 17(12):972-81. , Formato Vancouver: Aranda E, Aparicio J, Alonso V, García Albeniz X, García Alfonso P, Salazar R et al. SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015. Clin Transl Oncol. 2015 Dec;17(12):972-81.

Place Hold on SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015.

SEOM clinical guidelines in early-stage breast cancer 2015.

By Ciruelos Gil, Eva María. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2015 . 17(12):939-45. , Formato Vancouver: García Sáenz JA, Bermejo B, Estevez LG, Palomo AG, González Farre X, Margeli M et al. SEOM clinical guidelines in early-stage breast cancer 2015. Clin Transl Oncol. 2015 Dec;17(12):939-45.

Place Hold on SEOM clinical guidelines in early-stage breast cancer 2015.

SEOM guidelines for the management of Malignant Melanoma 2015.

By Martín, J.A.L.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2015 . 17(12):1030-5. , Formato Vancouver: Berrocal A, Arance A, Espinosa E, Castaño AG, Cao MG, Larriba J et al. SEOM guidelines for the management of Malignant Melanoma 2015. Clin Transl Oncol. 2015 Dec;17(12):1030-5.

Place Hold on SEOM guidelines for the management of Malignant Melanoma 2015.

Seom guidelines for the treatment of gastric cancer 2015.

By Grávalos Castro, Cristina. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2015 . 17(12):996-1004. , Formato Vancouver: Martin Richard M, Custodio A, García Girón C, Grávalos C, Gómez C, Jiménez Fonseca P et al. Seom guidelines for the treatment of gastric cancer 2015. Clin Transl Oncol. 2015 Dec;17(12):996-1004.

Place Hold on Seom guidelines for the treatment of gastric cancer 2015.

Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology.

By Grávalos Castro, Cristina. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2015 . 17(10):763-71. , Formato Vancouver: Goday A, Barneto I, García Almeida JM, Blasco A, Lecube A, Grávalos C et al. Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology. Clin Transl Oncol. 2015 Oct;17(10):763-71.

Place Hold on Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology.

Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.

By Manso Sánchez, Luis | Ciruelos Gil, Eva María. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2015 . 17(2):160-6. , Formato Vancouver: Salvador J, Manso L, De la Haba J, Jaén A, Ciruelos E, De Villena MC et al. Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer. Clin Transl Oncol. 2015 Feb;17(2):160-6.

Place Hold on Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.

Clinical guideline seom: hereditary colorectal cancer.

By Robles Díaz, Luis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2015 . 17(12):962-71. , Formato Vancouver: Guillén Ponce C, Serrano R, Sánchez Heras AB, Teulé A, Chirivella I, Martín T et al. Clinical guideline seom: hereditary colorectal cancer. Clin Transl Oncol. 2015 Dec;17(12):962-71.

Place Hold on Clinical guideline seom: hereditary colorectal cancer.

TTD consensus document on the diagnosis and management of exocrine pancreatic cancer.

By Grávalos Castro, Cristina. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of México. 2014 . 16(10):865-78. , Formato Vancouver: Benavides M, Abad A, Ales I, Carrato A, Díaz Rubio E, Gallego J et al. TTD consensus document on the diagnosis and management of exocrine pancreatic cancer. Clin Transl Oncol. 2014 Oct;16(10):865-78.

Place Hold on TTD consensus document on the diagnosis and management of exocrine pancreatic cancer.

Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain.

By Sepúlveda Sánchez, Juan Manuel. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2014 . 16(3):273-9. , Formato Vancouver: Balañá C, Vaz MA, López D, de la Peñas R, García Bueno JM, Molina Garrido MJ et al. Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain. Clin Transl Oncol. 2014 Mar;16(3):273-9.

Place Hold on Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain.

Oropharyngeal cancer related to Human Papilloma Virus: incidence and prognosis in Madrid, Spain.

By Ruiz Alonso, Ana. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2014 . 16(3):301-6. , Formato Vancouver: Cerezo L, de la Torre A, Hervás A, Ruiz A, Liñán O, López M, et al. Oropharyngeal cancer related to Human Papilloma Virus: incidence and prognosis in Madrid, Spain. Clin Transl Oncol. 2014 Mar;16(3):301-6.

Place Hold on Oropharyngeal cancer related to Human Papilloma Virus: incidence and prognosis in Madrid, Spain.

Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

By López Martín, José Antonio | Rodríguez Peralto, José Luis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2014 , Formato Vancouver: Martín-Algarra S, Fernández-Figueras MT, López-Martín JA, Santos-Briz A, Arance A, Lozano MD et al; Spanish Society of Pathology; Spanish Society of Medical Oncology. Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Clin Transl Oncol. 2014 Apr;16(4):362-73.

Place Hold on Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012.

By Mendiola Fernández, César. Clinical & Translational Oncology, 2013 . 15(7):509-25. , Formato Vancouver: González Martín A, Redondo A, Jurado M, De Juan A, Romero I, Bover I et al. GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012. Clin Transl Oncol. 2013 Jul;15(7):509-25.

Place Hold on GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012.

SEOM recommendations on the structure and operation of hereditary cancer genetic counseling units (HCGCUs).

By Robles Díaz, Luis. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013 . 15(1):20-5. , Formato Vancouver: Lastra-Aras E, Robles-Díaz L, Guillén-Ponce C, Alba E, Cruz JJ. SEOM recommendations on the structure and operation of hereditary cancer genetic counseling units (HCGCUs). Clin Transl Oncol. 2013 Jan;15(1):20-5.

Place Hold on SEOM recommendations on the structure and operation of hereditary cancer genetic counseling units (HCGCUs).

Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients.

By Ciruelos Gil, Eva María | Cortés-Funes Castro, Hernán | Dorta Suárez, Myriam | Ghanem Cañete, Ismael | Manneh Kopp, Ray | Manso Sánchez, Luis | Mendiola Fernández, César | Sepúlveda Sánchez, Juan Manuel | Valdiviezo N, | Vega Alonso, Estela. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013 . 15(6):467-71. , Formato Vancouver: Manso L, Valdiviezo N, Sepúlveda J, Ciruelos E, Mendiola C, Ghanem I, et al. Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients. Clin Transl Oncol. 2013 Jun;15(6):467-71.

Place Hold on Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients.

SEOM clinical guidelines for the adjuvant treatment of colorectal cancer 2013.

By Grávalos Castro, Cristina. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013 . 15(12):991-5. , Formato Vancouver: Maurel J, Grávalos C, Rivera F, Vera R, González Flores E; SEOM. SEOM clinical guidelines for the adjuvant treatment of colorectal cancer 2013. Clin Transl Oncol. 2013 Dec;15(12):991-5.

Place Hold on SEOM clinical guidelines for the adjuvant treatment of colorectal cancer 2013.

Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey.

By Sánchez Torres, José Miguel. Clinical & Translational Oncology. 2013 . 15(6):477-83. , Formato Vancouver: Steegmann JL, Sánchez Torres JM, Colomer R, Vaz Á, López J, Jalón I et al. Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey. Clin Transl Oncol. 2013 Jun;15(6):477-83.

Place Hold on Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey.

SEOM Clinical Guidelines for the systemic treatment of early breast cancer 2013.

By Ciruelos Gil, Eva María. Clinical & Translational Oncology, 2013 . 15(12):1011-7. , Formato Vancouver: Del Barco S, Ciruelos E, Tusquets I, Ruiz M, Barnadas A. SEOM. SEOM clinical guidelines for the systemic treatment of early breast cancer 2013. Clin Transl Oncol. 2013 Dec;15(12):1011-7.

Place Hold on SEOM Clinical Guidelines for the systemic treatment of early breast cancer 2013.

Effectiveness of oxaliplatin desensitization protocols.

By Aguilella Vizcaíno, María José | Cortés-Funes Castro, Hernán | Cortijo Cascajares, Susana | García Escobar, Ignacio | Herreros de Tejada López-Coterilla, Alberto. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013 . 15(3):219-25. , Formato Vancouver: Cortijo-Cascajares S, Nacle-López I, García-Escobar I, Aguilella-Vizcaíno MJ, Herreros-de-Tejada A, Cortés-Funes Castro H et al. Effectiveness of oxaliplatin desensitization protocols. Clin Transl Oncol. 2013 Mar;15(3):219-25.

Place Hold on Effectiveness of oxaliplatin desensitization protocols.

Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer.

By Grávalos Castro, Cristina. Clinical & Translational Oncology, 2013 . 15(9):705-11. , Formato Vancouver: Carrato A, Gómez A, Escudero P, Chaves M, Rivera F, Marcuello E et al. Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer. Clin Transl Oncol. 2013 Sep;15(9):705-11.

Place Hold on Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer.

SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma.

By Grávalos Castro, Cristina. Clinical and Translational Oncology, 2012 . 14(7):528-35. , Formato Vancouver: Rivera F, Grávalos C, García-Carbonero R. SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma. Clin Transl Oncol. 2012 Jul;14(7):528-35.

Place Hold on SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma.

Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen.

By Gómez Martín, Carlos. Clinical & translational oncology, 2012 . 14(9):689-97. , Formato Vancouver: Gómez-Martin C, Sánchez A, Irigoyen A, Llorente B, Pérez B, Serrano R, et al. Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen. Clin Transl Oncol. 2012 Sep;14(9):689-97.

Place Hold on Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen.

Functions and workload of medical oncologists in Spain.

By Grávalos Castro, Cristina. Clinical & Translational Oncology, 2012 . 14(6):423-9. , Formato Vancouver: Grávalos C, Salvador J, Albanell J, Barnadas A, Borrega P, García-Mata J, et al. Functions and workload of medical oncologists in Spain. Clin Transl Oncol. 2012 Jun;14(6):423-9.

Place Hold on Functions and workload of medical oncologists in Spain.

Conservative surgery, external radiotherapy, and HDR brachytherapy in a single fraction of 7 Gy in early breast cancer: long-term toxicity and esthetic assessment.

By Pérez-Regadera Gómez, José Fermín. Clinical and Translational Oncology, 2012 . 14(12):953-60. , Formato Vancouver: Rodríguez Pérez A, López Carrizosa MC, Samper Ots PM, Pérez-Regadera Gómez JF, Zapatero Ortuño J, Sáez Garrido Jde D,et al. Conservative surgery, external radiotherapy, and HDR brachytherapy in a single fraction of 7 Gy in early breast cancer: long-term toxicity and esthetic assessment. Clin Transl Oncol. 2012 Dec;14(12):953-60.

Place Hold on Conservative surgery, external radiotherapy, and HDR brachytherapy in a single fraction of 7 Gy in early breast cancer: long-term toxicity and esthetic assessment.

Epidemiology and prevalence of oropharyngeal candidiasis in Spanish patients with head and neck tumors undergoing radiotherapy treatment alone or in combination with chemotherapy.

By Ruiz Alonso, Ana. Clinical and Translational Oncology, 2012 . 14(10):740-6. , Formato Vancouver: Mañas A, Cerezo L, de la Torre A, García M, Alburquerque H, Ludeña B, et al. Epidemiology and prevalence of oropharyngeal candidiasis in Spanish patients with head and neck tumors undergoing radiotherapy treatment alone or in combination with chemotherapy. Clin Transl Oncol. 2012 Oct;14(10):740-6.

Place Hold on Epidemiology and prevalence of oropharyngeal candidiasis in Spanish patients with head and neck tumors undergoing radiotherapy treatment alone or in combination with chemotherapy.

Consensus of the Spanish Society of Radiation Oncology (SEOR) Brachytherapy Group on brachytherapy in Breast Cancer.

By Díaz Fuentes, Raúl | Murillo González, María Teresa. Clinical and Translational Oncology, 2012 . 14(3):177-82. , Formato Vancouver: Samper-Ots PM, Murillo MT, Díaz-Fuentes R, Guinot JL, et al. Consensus of the Spanish Society of Radiation Oncology (SEOR) Brachytherapy Group on Brachytherapy in breast cancer. Clin Transl Oncol. 2012 Mar;14(3):177-82.

Place Hold on Consensus of the Spanish Society of Radiation Oncology (SEOR) Brachytherapy Group on brachytherapy in Breast Cancer.

Consensus on treatment of endometrium carcinoma with brachytherapy.

By Pérez-Regadera Gómez, José Fermín. Clinical and Translational Oncology, 2012 . 14(4):263-70. , Formato Vancouver: Guinot JL, Pérez-Calatayud J, Azcoaga JM, Herruzo I, Bodineau C, Rovirosa A, et al. Consensus on treatment of endometrium carcinoma with brachytherapy. Clin Transl Oncol. 2012 Apr;14(4):263-70.

Place Hold on Consensus on treatment of endometrium carcinoma with brachytherapy.

Early-stage breast cancer conservative treatment: high-dose-rate brachytherapy boost in a single fraction of 700 cGy to the tumour bed.

By Pérez-Regadera Gómez, José Fermín. Clinical and Translational Oncology, 2012 . 14(5):362-8. , Formato Vancouver: Rodríguez Pérez A, Samper Ots PM, López Carrizosa MC, Pérez-Regadera Gómez JF, Zapatero Ortuño J, Sáez Garrido Jde D, et al. Early-stage breast cancer conservative treatment: high-dose-rate brachytherapy boost in a single fraction of 700 cGy to the tumour bed. Clin Transl Oncol. 2012 May;14(5):362-8.

Place Hold on Early-stage breast cancer conservative treatment: high-dose-rate brachytherapy boost in a single fraction of 700 cGy to the tumour bed.

Behaviour of breast cancer molecular subtypes through tumour progression.

By Andrés Esteban, Eva | Barcena García, Carmen | Ciruelos Gil, Eva María | Cortés-Funes Castro, Hernán. Clinical & Translational Oncology, 2012 . 14(6):481-5. , Formato Vancouver: Castañeda CA, Andrés E, Barcena C, Gómez HL, Cortés-Funés H, Ciruelos E. Behaviour of breast cancer molecular subtypes through tumour progression. Clin Transl Oncol. 2012 Jun;14(6):481-5.

Place Hold on Behaviour of breast cancer molecular subtypes through tumour progression.

A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer.

By Cortés-Funes Castro, Hernán | Grávalos Castro, Cristina. Clinical & Translational Oncology, 2012 . 14(8):606-12. , Formato Vancouver: Gravalos C, Salut A, García-Girón C, García-Carbonero R, León AI, Sevilla I, et al. A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer. Clin Transl Oncol. 2012 Aug;14(8):606-12.

Place Hold on A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer.

Biological markers of cisplatin resistance in advanced testicular germ cell tumours

By Ballestín Carcavilla, Claudio | Castellano, Daniel | Cortés-Funes Castro, Hernán. Clinical and Translational Oncology, 2012 . 14(6):452-457. , Formato Vancouver: García-Velasco A, Durán I, García E, Tarón M, Ballestín C, Castellanos D, et al. Biological markers of cisplatin resistance in advanced testicular germ cell tumours. Clin Transl Oncol. 2012;14(6):452-7.

Place Hold on Biological markers of cisplatin resistance in advanced testicular germ cell tumours

PITASOR epidemiological study: prevalence, incidence and treatment of anaemia in radiation therapy oncology departments in Spain

By Pérez Escutia, Mª Ángeles. Clinical and Translational Oncology, 2011 . 13(5):322-327. , Formato Vancouver: Samper Ots PM, Muñoz J, Biete A, Ortiz MJ, Acuña M, Cabrera J, et al. PITASOR epidemiological study: prevalence, incidence and treatment of anaemia in radiation therapy oncology departments in Spain. Clin Transl Oncol. 2011;13(5):322-7.

Place Hold on PITASOR epidemiological study: prevalence, incidence and treatment of anaemia in radiation therapy oncology departments in Spain

Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

By Cortés-Funes Castro, Hernán | Gómez Martín, Carlos | Grávalos Castro, Cristina. Clinical and Translational Oncology, 2011 . 13(3):179-184. , Formato Vancouver: Grávalos C, Gómez Martín C, Rivera F, Alés I, Queralt B, Márquez A, Jiménez U, Alonso V, et al. Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer. Clin Transl Oncol. 2011;13(3):179-84.

Place Hold on Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

Recommendations and expert opinion on the treatment of locally advanced rectal cancer in Spain

By Grávalos Castro, Cristina. Clinical & Translational Oncology, 2011 . 13(12):862-868. , Formato Vancouver: Grávalos C, García-Alfonso P, Afonso R, Arrazubi V, Arrivi A, Cámara JC, et al. Recommendations and expert opinion on the treatment of locally advanced rectal cancer in Spain. Clin Transl Oncol. 2011;13(12):862-8.

Place Hold on Recommendations and expert opinion on the treatment of locally advanced rectal cancer in Spain

SEOM clinical guidelines for the treatment of pancreatic cancer

By Gómez Martín, Carlos. Clinical and Translational Oncology, 2011 . 13(8):528-535. , Formato Vancouver: Gómez Martín C, Hidalgo M, Tabernero J, Isla D. SEOM clinical guidelines for the treatment of pancreatic cancer. Clin Transl Oncol. 2011;13(8):528-35.

Place Hold on SEOM clinical guidelines for the treatment of pancreatic cancer

Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain

By Castellano, Daniel. Clinical and Translational Oncology, 2011 . 13(12):869-877. , Formato Vancouver: Calvo Aller E, Maroto P, Kreif N, González Larriba JL, López-Brea M, Castellano D, et al. Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain. Clin Transl Oncol. 2011;13(12):869-77.

Place Hold on Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain

Update on the diagnosis of cancer of unknown primary (CUP) origin

By Hitt Sabag, Ricardo | Homet, Blanca. Clinical and Translational Oncology, 2011 . 13(7):434-441. , Formato Vancouver: Ariza A, Balañá C, Concha Á, Hitt R, Homet B, Matilla A, Alba E. Update on the diagnosis of cancer of unknown primary (CUP) origin. Clin Transl Oncol. 2011Jul;13(7):434-41.

Place Hold on Update on the diagnosis of cancer of unknown primary (CUP) origin